Auflistung nach Autor "Naehrlich, Lutz"
Anzeige der Dokumente 1-4 von 4
-
Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study
Klotter, Victoria; Gunchick, Caroline; Siemers, Enno; Rath, Timo; Hudel, Helge; Naehrlich, Lutz; Roderfeld, Martin; Roeb, Elke (2017)About 30% of patients with Cystic Fibrosis (CF) develop CF-associated liver disease (CFLD). Recent studies have shown that transient elastography (TE), as a method to quantify liver stiffness, allows non-invasive diagnosis ... -
Identification of neutrophil activation markers as novel surrogate markers of CF lung disease
Rath, Timo; Zwaschka, Lisa; Hage, Lisa; Kügler, Marion; Menendez, Katrin; Naehrlich, Lutz; Schulz, Richard; Roderfeld, Martin; Roeb, Elke (2014)Background and aims: Cystic Fibrosis (CF) lung disease is characterized by progressively declining lung function and represents a major factor contributing to the high morbidity and mortality associated with CF. However, ... -
Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis : a case-control study
Bagheri-Hanson, Azadeh; Nedwed, Sebastian; Rueckes-Nilges, Claudia; Naehrlich, Lutz (2014)BACKGROUND:Nasal potential difference (NPD) and intestinal current measurement (ICM) are functional CFTR tests that are used as adjunctive diagnostic tools for cystic fibrosis (CF). Smoking has a systemic negative impact ... -
Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease
Rath, Timo; Hage, Lisa; Kügler, Marion; Menendez Menendez, Katrin; Zachoval, Reinhart; Naehrlich, Lutz; Schulz, Richard; Roderfeld, Martin; Roeb, Elke (2013)Background and Aims Cystic Fibrosis associated liver disease (CFLD) develops in approximately 30% of CF patients. However, routine sensitive diagnostic tools for CFLD are lacking. Within this study, we aimed to identify ...